Search results
Results from the WOW.Com Content Network
ADHD medication tied to 19% lower death risk. An observational study conducted in Sweden, whose results appeared in JAMA in March 2024, further emphasized the positive impact of ADHD medication on ...
“The clinician’s primary job is to determine why symptoms of inattention are concerning and whether they are best attributed to ADHD, anxiety, depression, sleep, stress, changes in context ...
Barbiturates such as pentobarbital have been shown to cause paradoxical hyperactivity in an estimated 1% of children, who display symptoms similar to the hyperactive-impulsive subtype of attention deficit hyperactivity disorder. Intravenous caffeine administration can return these patients' behavior to baseline levels. [11]
Attention deficit hyperactivity disorder (ADHD) [1] is a neurodevelopmental disorder characterized by executive dysfunction occasioning symptoms of inattention, hyperactivity, impulsivity and emotional dysregulation that are excessive and pervasive, impairing in multiple contexts, and developmentally-inappropriate.
Adult Attention Deficit Hyperactivity Disorder is the persistence of attention deficit hyperactivity disorder (ADHD) into adulthood. It is a neurodevelopmental disorder, meaning impairing symptoms must have been present in childhood, except for when ADHD occurs after traumatic brain injury.
Overall, the results suggest that heart disease risk was 23% higher for people who have used ADHD medication for more than five years compared with those who did not take medication — but that ...
Racing thoughts refers to the rapid thought patterns that often occur in manic, hypomanic, or mixed episodes.While racing thoughts are most commonly described in people with bipolar disorder and sleep apnea, they are also common with anxiety disorders, obsessive–compulsive disorder (OCD), and other psychiatric disorders such as attention deficit hyperactivity disorder (ADHD).
Large, high quality research has found small differences in the brain between ADHD and non-ADHD patients. [1] [15] Jonathan Leo and David Cohen, critics who reject the characterization of ADHD as a disorder, contended in 2003 and 2004 that the controls for stimulant medication usage were inadequate in some lobar volumetric studies, which makes it impossible to determine whether ADHD itself or ...